In addition, it has been reported that activated MAPK3/1 (ERK1/2) overexpression in PC, and the activity of ERK1/2 can protect PC cells from chemotherapy-induced apoptosis [68]. The gene discussed is MAPK3; the disease is pachyonychia congenita.